A method is described for direct analysis of lead in blood utilizing the carbon rod atomizer. Aliquots of whole blood are analyzed without pre-treatment. Resuits are comparable to those for a similar non-flame technique in which whole blood samples were prediluted with "Triton X-100." The small sample volumes required and the minimal sample preparation further diminish the possibility of spurious contamination.
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The advantages of non-flame atomization in atomic absorption spectrophotometry have been previously documented. Procedures for the analysis of lead in whole blood have cited various methods of sample pre-treatment before analysis.
We present here a simple, reagent-free method for the direct analysis of lead in 0.5 il of whole blood, by use of the carbon rod atomizer (CRA) in conjunction with atomic absorption spectrophotometry. Cooling water was circulated to the CRA at the rate of 1.0 liter/mm, with about 1 mm of cooling time allowed between injections. Non-atomic contribution during the atomize cycle was monitored by using a hydrogen continuum lamp operated at 217.0 nm. Background correction was measured on each separate sample, as in ref. 
Materials and Methods

Apparatus
3200-xF213;
Becton, Dickinson and Co., Rutherford, N. J. 07070).
Procedure
Lead in whole blood was measured both by a reagentfree direct method and a Triton X-100 dilution method (1).The Triton method involved diluting whole blood with two volumes of a Triton X-100 (50 mI/liter) solution and directly applying 1 of the dilution to the CRA. In the previous publication cited above all data were collected with the Model 61 CRA. For this report, the Model 63 CRA was used.
The direct analysis of blood lead involved applying 0.5 M1 of whole blood to the CRA. Standards for both methods were prepared in a whole blood matrix as previously described (1) . Parameters for the operation of the CRA were identical for both methods; the ash time for the Triton dilution method was decreased to lOs.
In our approach to the development of a direct method for the analysis of lead in whole blood utilizing the CRA, we were confronted by two limiting factors. The first was the difficulty in precisely pipetting small volumes (<1 l) of whole blood. The second was the excessive ash buildup in the carbon tube resulting from the direct analysis of whole blood samples. Hence, preliminary data were collected to determine that 0.5 l was in fact the optimum amount of whole blood that could be precisely pipetted into the tube without excessive ash buildup. It should be mentioned that initial injections of 0.5 l of whole blood into a fresh carbon tube resulted in a small amount of ash residue being left in the tube after atomization.
We noticed that this small residue kept successive 0.5-1d injections from frothing during the dry and ash cycles. Frothing causes the light beam through the tube to be blocked, and, hence, the recorder pen fails to return to the baseline before the sample is atomized.
In the absence of frothing, we noticed no excessive ash buildup (i.e., a rise in baseline) over a range of 40 injections (standards plus 10 duplicate samples). However, sensitivity was slightly decreasedby the end of the analysis.
A direct result of the difficulty encountered in pipetting small aliquots of whole blood can be seen in Table 1 . It is evident from the coefficients of variation that the delivery of 0.5 jl of whole blood is not as precise as the delivery of 1.0 Ll of a diluted hemolysate. However, despite the decreased precision, this method can adequately account for lead added to whole blood in clinically significant amounts, as evidenced by Table 2 . This compares favorably with the Triton dilution method, which demonstrated an average 96.1% recovery over about the same concentration range (1). We have not determined the effect of other cations and anions in blood on the results; we do not believe their differences among blood samples would be of clinical significance.
Results of the direct method correlated well with the Triton dilution method, for routine clinical samples (Table 3 ).
The sensitivity of the direct method is 10 ng/ml, and the linearity of the working standard curve extends to 75 ig/10O ml; beyond this value it is not quite linear, but can still be used with validity, as Tables 2 and 3 show. The method offers simplicity and freedom from spurious contamination.
In addition, the fact that a 0.5-id sample is adequate makes this an ideal method for pediatric sampling.
